Looking for a disruptive equipment mounting solution? Here is one to consider.
A standardized system can simplify, streamline, and ruggedize the mounting of tools, instrumentation, and other equipment in the healthcare setting.
Scouting Opportunity for Modified Transdermal Patch Drug Delivery System for Diabetes, Parkinson’s, and Other Indications
Our client is currently developing a revolutionary new transdermal drug delivery system that leverages the benefits of ultrasound.
Outlicensing Opportunity for Technology Platform for Co-Development and Licensing in Oncology and Vaccines
ur client is currently developing a new functionalized silica nanoparticle as a drug delivery vector for nucleic acid payloads.
Scouting Opportunity for Pharmaceutical products marketed in Europe and specifically Germany within Anesthetics and Analgesic
Our client wishes to acquire injectable products that are currently marketed in Germany.
Seeking Partner for Speech Analysis Technology Platform for use in HDMI pass-through devices, end user devices, content provider software
Our client has developed a digital signal processing algorithm and system that effectively removes undesired audio from television programming.
Scouting for Specific Prescription Rx and Generics in Respiratory, Diabetes, Ophthalmology, Anti-coagulant, Hypertension, Antibiotic, Analgesics for the Saudi Arabian Markets
Our client is identifying pharmaceuticals for in-licensing, supply, and tech transfer with regional exclusivity in Saudi Arabia.
Outlicensing opportunity for Proprietary Compound and Nasal Spray for the Treatment of Obesity
Both ABSOLVE and ABSCENT have been evaluated in the clinic and have been more effective / better tolerated than other obesity therapeutics.
Average weight loss is 10 lbs. during the first month’s use (observed range = 4 lbs. to 15 lbs.) and 2 lbs. to 10 lbs. per month thereafter.
ABSOLVE’s APIs are both components of other diet medicines.
Seeking Investment for Osteoarthritis Disease Modification Pharmaceutical
First in class, disease-modifying, once a year infusion for osteoarthritis. Company seeking investment
Scouting Opportunity for Prescription, Orphan, Specialty for Switzerland
Our client is a pharmaceutical company seeking US FDA and/or EMA approved Prescription (Rx) Drugs and Medical Foods for the Swiss market in Oncology, Hematology, Infectious Disease, Hepatology, Gastrology, Transplant, Hematology, and Hepatology.
Outlicensing Opportunity for Implantable Testosterone Pellets for Regions Outside of the UK
Our client has developed a subcutaneous testosterone implant system that overcomes disadvantages with competing HRT products.
Newer postsOlder posts